Literature DB >> 901740

The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease.

A Clay, A Swain, J R Trounce.   

Abstract

1 Quadruple chemotherapy with cytotoxic drugs in advanced (Stage IIIB) Hodgkin's disease causes a fall in the blood lymphocyte count with recovery 1 month after stopping treatment. 2 No selective effect on the T or B lymphocyte populations was shown.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 901740      PMCID： PMC1429059          DOI： 10.1111/j.1365-2125.1977.tb00765.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  21 in total

1.  A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas.

Authors:  D LAMB; F PILNEY; W D KELLY; R A GOOD
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

2.  A study of skin homografting in patients with lymphomas.

Authors:  I GREEN; P F CORSO
Journal:  Blood       Date:  1959-03       Impact factor: 22.113

3.  Rosette formation in Hodgkin's disease.

Authors:  A Swain; J R Trounce
Journal:  Oncology       Date:  1974       Impact factor: 2.935

4.  Herpes Zoster-Varicella infections and lymphoma.

Authors:  D R Goffinet; E J Glatstein; T C Merigan
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow.

Authors:  J W Moorhead; H N Claman
Journal:  Cell Immunol       Date:  1972-09       Impact factor: 4.868

7.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

8.  Significance of the changes in the circulating lymphoid cells in Hodgkin's disease.

Authors:  D Cowther; G H Fairley; R L Sewell
Journal:  Br Med J       Date:  1969-05-24

9.  Response to BCG vaccination and survival in advanced Hodgkin's disease.

Authors:  J E Sokal; C W Aungst
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

10.  Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

Authors:  P G Scheurlen; W Schneider; A Pappas
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.